GlassScriptPhysician profile
Andrew J Brown
NPI 1619388857
$7,679.58
in general payments reported to CMS, 2019-2025
42 companies · $4,558 in 2025
The $4,558 reported for 2025 was more than what 93% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $335 · 2020: $49.77 · 2021: $191 · 2022: $1,587 · 2023: $367 · 2024: $592 · 2025: $4,558.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $4,388 · Food and Beverage: $1,130.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $4,387.50 |
| Food and Beverage | $1,129.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vilex LLC | $4,387.50 | 2025 | Nitinex |
| Cdc Medical LLC | $1,220.98 | 2022-2023 | |
| Stryker Corporation | $267.30 | 2019-2024 | Variax, Augment Injectable, Ortholoc 2 Lapifuse |
| Nevro Corp. | $253.55 | 2022-2024 | Senza |
| Smith+Nephew, INC. | $210.13 | 2019-2025 | Grafix Pl, Jet-X, Stravix Mesh |
| Ani Pharmaceuticals, INC. | $111.54 | 2024-2025 | Purified Cortrophin Gel |
| Paragon 28, INC. | $106.78 | 2019-2023 | Phantom Metatarsal Shortening |
| Trice Medical, INC. | $97.26 | 2021 | |
| Bioventus LLC | $85.78 | 2019-2025 | Theragenesis Bilayer Wound Matrix, Exogen Ultrasound Bone Healing System |
| Paratek Pharmaceuticals, INC. | $72.09 | 2022-2024 | Nuzyra |
| Kowa Pharmaceuticals America, INC. | $58.82 | 2022-2023 | Seglentis |
| Organogenesis INC. | $53.59 | 2021-2024 | Affinity |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $49.28 | 2022-2023 | Jublia |
| Zimmer Biomet Holdings, INC. | $45.38 | 2022 | |
| Treace Medical Concepts, INC. | $42.88 | 2024 |
Show all 42 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $42.14 | 2024-2025 | Exparel |
| Grt US Holding, INC. | $39.68 | 2021-2022 | |
| Kerecis Limited | $38.02 | 2022 | |
| Kci USA, INC. | $34.68 | 2023 | Promogran Prisma, Activ.A.C. Ion Progress |
| Nabriva Therapeutics, Plc | $32.84 | 2021 | |
| Solventum Corporation | $31.52 | 2024 | Activ.A.C. |
| Avanos Medical | $30.53 | 2022 | |
| Depuy Synthes Sales INC. | $29.12 | 2022 | |
| Orthofix Medical, INC. | $27.75 | 2019-2023 | Physio-Stim |
| Convatec INC. | $26.99 | 2023 | |
| Alexion Pharmaceuticals, INC. | $23.56 | 2025 | Strensiq |
| Siemens Medical Solutions USA, INC. | $20.80 | 2024 | Magnetom Free.Max |
| Wright Medical Technology, INC. | $20.15 | 2019 | |
| Inari Medical, INC. | $20.15 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Mimedx Group, INC. | $19.80 | 2025 | |
| Abbott Laboratories | $17.81 | 2022 | |
| Medtronic, INC. | $17.36 | 2022 | |
| Averitas Pharma INC. | $17.25 | 2023 | Qutenza |
| Stability Biologics, LLC | $17.23 | 2022 | |
| Arteriocyte Medical Systems, INC. | $16.39 | 2020 | |
| Curonix LLC | $16.15 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Vertex Pharmaceuticals Incorporated | $15.90 | 2025 | |
| Cashflow Solutions, LLC | $13.99 | 2023 | Pcd-51 731a (US) - White, Lympha Press Optimal Plus(US) Bt, Pcd-52 737a (US) White |
| Arthrosurface Incorporated | $12.65 | 2019 | |
| Melinta Therapeutics, LLC | $12.08 | 2019 | |
| Integra Lifesciences Corporation | $11.37 | 2020 | |
| Dynasplint Systems INC. | $10.81 | 2023 | Dynasplint |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Brown listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.